Trial Profile
Prospective Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Who Are Not Well Controlled With, or Intolerant of, Topical or Systemic Corticosteroids
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2018
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Uveitis
- Focus Therapeutic Use
- 25 Sep 2018 Status changed from recruiting to discontinued.
- 01 Nov 2017 Status changed from not yet recruiting to recruiting.
- 19 May 2016 New trial record